scispace - formally typeset
Open AccessJournal Article

Montelukast as a treatment modality for eosinophilic gastroenteritis.

Reads0
Chats0
TLDR
In this paper, a 38-year old man with steroid-dependent eosinophilic Gastroenteritis (EG) was successfully treated with montelukast, a leukotriene receptor antagonist.
Abstract
Eosinophilic Gastroenteritis (EG) is a rare condition, caused by eosinophilic inflammatory infiltrates in the gastrointestinal tract. It is usually treated successfully with systemic glucocorticoids. Because of frequent relapses, however, there is need for alternatives. We describe a 38-year old man with steroid-dependent EG, who was successfully treated with montelukast, a leukotriene receptor antagonist. It inhibits leukotriene D4, an important cytokine in the inflammatory cascade. Although montelukast could not replace steroid therapy, it acted as a steroid sparing agent in our patient. Review of the literature shows that montelukast is efficient in the treatment of EG in a part of the patients. The low cost, the low number of side effects and its efficiency make it an interesting alternative in relapsing or steroid dependent EG. There is need for multicentric studies regarding the treatment of EG.

read more

Citations
More filters
Journal ArticleDOI

Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function

TL;DR: A review of selective cysLT receptor-1 (cysLTR1) antagonists, specifically montelukast, pranlukast, and zafirlukast can be found in this paper.
Journal ArticleDOI

Eosinophilic gastroenteritis: an update

TL;DR: The natural history of EGE includes three different evolutionary patterns, since patients may suffer a single outbreak, a recurrent course or even chronic disease.
Journal ArticleDOI

Eosinophilic gastroenteritis: Approach to diagnosis and management.

TL;DR: An algorithm is designed and applied to clarify the steps to follow for diagnosis of EGE in clinical practice and to summary of various therapeutic modalities for EGE management according to disease severity upon presentation.
Journal ArticleDOI

Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis

TL;DR: With the seeming increase in all types of EGIDs, phenotypic descriptions are emerging that will likely promote better understanding of the pathogenesis and identification of novel therapeutic targets.
Journal ArticleDOI

Eosinophilic gastrointestinal diseases – Pathogenesis, diagnosis, and treatment

TL;DR: Three useful options for treating EoE patients are acid inhibitors, swallowed topical corticosteroids, and an elimination diet, while systemic administration of glucocorticoids is the standard treatment of EGE, though information is limited.
References
More filters
Journal ArticleDOI

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.

TL;DR: Eos inophilic gastroenteritis should be considered in the differential diagnosis of unexplained gastrointestinal symptoms even in the absence of peripheral eosinophilia, according to the clinicopathological spectrum.
Journal ArticleDOI

Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis

TL;DR: Anti-IL-5 therapy is associated with marked decreases in peripheral blood and esophageal eosinophilia in patients with EE and improved clinical outcomes, and is a promising therapeutic intervention for EE.
Journal ArticleDOI

Eosinophilic gastroenteritis: Clinical experience with 15 patients

TL;DR: Eosinophilic gastroenteritis is a rare condition of unclear etiology characterized by relapses and remissions and short courses of corticosteroids are the mainstay of treatment, although some patients with relapsing disease require long-term low-dose steroids.
Journal ArticleDOI

Anti-IgE treatment of eosinophil-associated gastrointestinal disorders

TL;DR: It is demonstrated that IgE-mediated processes contribute to the generation of eosinophilic inflammation in EGIDs and suggest that anti-IgE therapy might be effective in these disorders.
Related Papers (5)